News
Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event Authors: Malvi Thakker, MD [email protected], Kalimullah Quadri, MD, Ankuri Desai, MD, Wajiha ...
Hosted on MSN2mon
Ionis reports positive data from study of olezarsen for ...
Ionis Pharmaceuticals has reported positive topline outcomes from the randomised, global Phase III Essence study of Tryngolza (olezarsen) in individuals with moderate hypertriglyceridemia and, or ...
Provided by PR Newswire Mar 17, 2025, 4:00:00 AM Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia ...
Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event Authors: Malvi Thakker, MD [email protected], Kalimullah Quadri, MD, Ankuri Desai, MD, Wajiha ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback